thiotepa has been researched along with Adrenal Cancer in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Excerpt | Relevance | Reference |
---|---|---|
"Myeloablative treatment intensification in 25 patients diagnosed when older than 12 months of age with stage IV neuroblastoma included sequential delivery of cisplatin 120 mg/m2 x 1, hyperfractionated radiation (2,100 cGy) to the primary site and adjacent lymph nodes, carmustine (BCNU) 200 mg/m2 x 1, melphalan 60 mg/m2/d x 3 (n = 13) or thiotepa 300 mg/m2/d x 3." | 3.68 | Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. ( Cheung, NK; Gulati, SC; Kushner, BH; LaQuaglia, M; Mandell, LR; O'Reilly, RJ, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Honda, S | 1 |
Miyagi, H | 1 |
Minato, M | 1 |
Kubota, KC | 1 |
Okada, T | 1 |
Kushner, BH | 1 |
O'Reilly, RJ | 1 |
Mandell, LR | 1 |
Gulati, SC | 1 |
LaQuaglia, M | 1 |
Cheung, NK | 1 |
1 review available for thiotepa and Adrenal Cancer
Article | Year |
---|---|
Hemorrhagic shock due to spontaneous rupture of adrenal neuroblastoma in an infant: a rare case and review of the literature.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Crystalloid Solu | 2012 |
1 other study available for thiotepa and Adrenal Cancer
Article | Year |
---|---|
Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation | 1991 |